Title : Simultaneous proteasome and autophagy inhibition synergistically enhances cytotoxicity of doxorubicin in breast cancer cells.

Pub. Date : 2022 Jun

PMID : 35485606






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Doxorubicin and ixazomib cotreatment increased Beclin-1 (3.8- and 3.5-fold) and LC3-II expression (13.5- and 1.9-fold) in MDA-MB-231 and MCF-7 cells, respectively. ixazomib beclin 1 Homo sapiens